Comorbidities, symptoms and end-of-life medication use in hospitalised decedents before and during the COVID-19 pandemic: a retrospective regional cohort study in Ottawa, Canada

Peter G Lawlor ,Leila Cohen,Samantha Rose Adeli,Ella Besserer,Valérie Gratton,Brandi Vanderspank‐Wright ,Shirley H Bush ,Rebekah Murphy,Chelsea Noël ,Sarina R Isenberg ,Grace Warmels,Adrianna Bruni,Monisha Kabir,Brandon Heidinger,Koby Anderson,Kyle Arsenault-Mehta,Krista Wooller,Julie Lapenskie,Colleen Webber,Daniel Bedard,Paula Enright,Isabelle Desjardins,Khadija Bhimji,Claire Dyason,Akshai Iyengar,Peter Tanuseputro,James Downar,Henrique A Parsons

doi:10.1136/bmjopen-2023-075518

Comorbidities, symptoms and end-of-life medication use in hospitalised decedents before and during the COVID-19 pandemic: a retrospective regional cohort study in Ottawa, Canada

Peter G Lawlor , Leila Cohen + Show 26 more

Open Access

https://doi.org/10.1136/bmjopen-2023-075518

Copy DOI

Journal: BMJ open	Publication Date: Sep 1, 2023
License type: CC BY-NC 4.0

Affiliation: University of Ottawa, Ottawa Hospital, Bruyère, Queensway-Carleton Hospital, University of Toronto, Montfort Hospital, Institut du Savoir Montfort

#Morphine Equivalent Daily Dose #Medication Use + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveTo compare comorbidities, symptoms and end-of-life (EoL) palliative medication (antisecretories, opioids, antipsychotics and sedatives) use among decedents before and during the COVID-19 pandemic.DesignIn a retrospective cohort study, decedent records in...

Full Text